Authors:
GAMELIN E
BOISDRONCELLE M
DELVA R
REGIMBEAU C
CAILLEUX PE
ALLEAUME C
MAILLET ML
GOUDIER MJ
SIRE M
PERSONJOLY MC
MAIGRE M
MAILLART P
FETY R
BURTIN P
LORTHOLARY A
DUMESNIL Y
PICON L
GESLIN J
GESTA P
DANQUECHINDORVAL E
LARRA F
ROBERT J
Citation: E. Gamelin et al., LONG-TERM WEEKLY TREATMENT OF COLORECTAL METASTATIC CANCER WITH FLUOROURACIL AND LEUCOVORIN - RESULTS OF A MULTICENTRIC PROSPECTIVE TRIAL OF FLUOROURACIL DOSAGE OPTIMIZATION BY PHARMACOKINETIC MONITORING IN 152 PATIENTS, Journal of clinical oncology, 16(4), 1998, pp. 1470-1478
Authors:
LAMEZEC B
ALLEAUME C
GAMELIN E
GOUDIER MJ
CAILLEUX PE
DANQUECHINDORVAL E
SIRE M
MAILLET ML
MAIGRE M
GESTA P
MAILLART P
LARRA F
Citation: B. Lamezec et al., LONG-TERM WEEKLY TREATMENT OF ADVANCED COLORECTAL-CANCER (CRC) WITH FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) - 5 YEAR-RESULTS OF A MULTICENTRIC PHASE-II TRIAL OF 5-FU PHARMACOKINETIC MONITORING IN 152 PATIENTS, European journal of cancer, 33, 1997, pp. 726-726
Authors:
GANEM G
DUBRAY B
RAOUL Y
COLIN P
BARDET E
DOUILLARD JY
GOUDIER MJ
HENNEQUIN C
WALTER S
MICHELLANGLET P
MARTIN P
MARON D
MORVAN F
ANDOLENKO P
EXTRA JM
Citation: G. Ganem et al., CONCOMITANT CHEMORADIOTHERAPY FOLLOWED, WHERE FEASIBLE, BY SURGERY FOR CANCER OF THE ESOPHAGUS, Journal of clinical oncology, 15(2), 1997, pp. 701-711
Citation: Ec. Gamelin et al., RELATIONSHIP BETWEEN 5-FLUOROURACIL (5-FU) DOSE INTENSITY AND THERAPEUTIC RESPONSE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER RECEIVING INFUSIONAL THERAPY CONTAINING 5-FU, Cancer, 77(3), 1996, pp. 441-451
Authors:
GAMELIN E
DELVA R
DUMASNIL Y
JACOB J
MAILLART P
CALLE MB
GOUDIER MJ
LORTHOLARY A
HARDOUIN A
GESLIN J
HETROY J
LARRA F
Citation: E. Gamelin et al., HIGH-DOSE 5FU BIOMODULATION BY HIGH-DOSE LEUCOVORIN AND INDIVIDUAL 5FU DOSE ADJUSTMENT IN METASTATIC COLORECTAL-CANCER - A MULTICENTRIC PROSPECTIVE-STUDY OF 130 PATIENTS, European journal of cancer, 31A, 1995, pp. 729-729
Authors:
FUMOLEAU P
DELGADO FM
DELOZIER T
MONNIER A
DELGADO MAG
KERBRAT P
GARCIAGIRALT E
KEILING R
NAMER M
CLOSON MT
GOUDIER MJ
CHOLLET P
LECOURT L
MONTCUQUET P
Citation: P. Fumoleau et al., PHASE-II TRIAL OF WEEKLY INTRAVENOUS VINORELBINE IN 1ST-LINE ADVANCEDBREAST-CANCER CHEMOTHERAPY, Journal of clinical oncology, 11(7), 1993, pp. 1245-1252